Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Medfusion Syringe Pump Recall Issued Over Software Errors Similar problems have plagued various Medtronic syringe pumps over the last couple years, leading to multiple recalls March 6, 2024 Hannah Brown Add Your Comments Smiths Medical is recalling more than 85,000 Medfusion Syringe Pumps due to software problems that can cause medication errors, which have already been linked to at least one patient injury. The U.S. Food and Drug Administration (FDA) announced the Medfusion 3500 Syringe Pump recall on March 5, indicating that the software defect may cause the pumps to malfunction during administration, resulting in either excessive or insufficient delivery of medication, blood, or fluids. The Medfusion syringe pumps are used to administer fluids, medications, and other substances in precise quantities. They are commonly utilized in critical care, anesthesia, neonatal, and pediatric settings. Smiths Medical previously announced a recall for these products in December 2023, after discovering problems with how the syringe pumps were delivering insulin and other drugs. The pumps were found to have a software defect that causes them to administer to too much or too little of vital medications, blood, or fluids, which could lead to serious injury or death. MEDTRONIC MINIMED LAWSUITS Did you or a loved one receive a Medtronic MiniMed insulin pump? Recalled Medtronic MiniMed insulin pumps have been linked to reports of hypoglycemia, hyperglycemia and other serious injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION MEDTRONIC MINIMED LAWSUITS Did you or a loved one receive a Medtronic MiniMed insulin pump? Recalled Medtronic MiniMed insulin pumps have been linked to reports of hypoglycemia, hyperglycemia and other serious injuries. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Medfusion Syringe Pumps Recall The recall affects an estimated 85,961 units of the Model 3500 Medfusion syringe pumps, which were distributed between August 9, 2002 and August 15, 2023. According to the recall notice, the affected Medfusion syringe pumps have problems linked to earlier software versions that can affect the alarm system, the pump, and the control screen. These issues could cause the pump to fail if undetected, resulting in a delay or interruption of the delivery of life-saving drugs. The manufacturer indicates that there are ten software malfunctions affecting various serial numbers and software versions. These malfunctions have the potential to cause serious harm or death to patients due to under or over-infusion, as well as delays in the delivery of critical medications to patients. A complete list of the affected software versions is included in the recall notice. Smiths Medical initially reported similar problems in April 2022, resulting in a recall of more than 118, 000 Medfusion Syringe Infusion Pumps in July of that year. Last month, similar problems led to a Medfusion 4000 Syringe Pump recall affecting more than 50,000 devices. For this latest recall, an Urgent Medical Device Correction letter was sent to customers on December 19, asking them to locate all of the affected pumps and ensure that users are immediately aware of the potential problems and what to do if they occur. It also urged customers to ensure that their Medfusion pumps have the most recent software installed and to complete the response form provided. The completed forms should be returned to smithmedical6114@sedgwick.com within ten days of receiving the letter. Customers with further questions regarding this recall can contact Smiths Medical at 1-866-216-8806. Side effects or adverse events should also be reported to the FDA’s MedWatch Adverse Event Reporting Program. Tags: Drug Overdose, Insulin, Medfusion Syringe Pump, Medication Error, Smiths Medical, Syringe Pump Recall More Medtronic MiniMed Lawsuit Stories Medtronic MiniMed Insulin Pump Recall Over Battery Failure Risks October 7, 2024 FDA Issues “Do Not Use” Warning for Recalled Medtronic NIM Endotracheal Tubes July 10, 2024 Medfusion Syringe Pump Recall Issued After Software Error Linked to Injury Risk February 15, 2024 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025) Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025) Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (Posted: today) As new BioZorb lawsuits continue to be filed over complications with the recalled breast tissue markers, lawyers indicate they are on track for the first of four test cases to go before a jury in September 2025. MORE ABOUT: BIOZORB LAWSUITCourt Clears BioZorb Lawsuit Design Defect Claims Over Recalled Breast Tissue Marker (03/26/2025)Group of 7 BioZorb Injury Lawyers Appointed to Leadership Positions in Lawsuits Over Recalled Breast Tissue Marker (03/19/2025)Breast Cancer Survivors File Lawsuit Over Recalled BioZorb Tissue Marker (03/12/2025)
Depo-Provera Meningioma Diagnosis Information Required To Qualify for Lawsuit: Order (Posted: yesterday) Women pursuing Depo-Provera meningioma lawsuits will have to provide documentary proof of their diagnosis and the versions of the birth control shot they received within 120 days of filing their case. MORE ABOUT: DEPO-PROVERA LAWSUITDepo-Provera Lawsuit Timeline for Preparing Pilot Trial Cases Outlined by MDL Judge (03/24/2025)Women Can File Depo-Provera Brain Tumor Lawsuits Directly in MDL: Court Order (03/18/2025)75 Lawyers in Depo-Provera Lawsuits Seek MDL Leadership Roles (03/10/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: 2 days ago) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)